search
Back to results

Erector Spinae Plane Block for Post-nephrectomy Pain

Primary Purpose

Pain, Postoperative

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Morphine patient controlled analgesia
Erector Spinae plane block
Sponsored by
National Cancer Institute, Egypt
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Postoperative

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Physical status ASA II.
  • Age ≥ 18 and ≤ 65 Years.
  • Body mass index (BMI): > 20 kg/m2 and < 40 kg/m2.

Exclusion Criteria:

  • Patient refusal
  • Known sensitivity or contraindication to local anesthetics.
  • History of psychological disorders.
  • Localized infection at the site of block.

    • Coagulopathies with platelet count below 50,000 or an INR>1.5.

Sites / Locations

  • National Cancer Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

patient controlled analgesia

Erector Spinae plane block

Arm Description

30 patients will receive only postoperative IV PCA alone for postoperative analgesia.

30 patients will receive continuous ESPB for postoperative analgesia.

Outcomes

Primary Outcome Measures

measurement of visual analogue score
it is a scoring system from 0 to 100 mm where 100 represents the worst pain and 0 indicates no pain

Secondary Outcome Measures

Full Information

First Posted
August 28, 2020
Last Updated
July 20, 2022
Sponsor
National Cancer Institute, Egypt
search

1. Study Identification

Unique Protocol Identification Number
NCT04537598
Brief Title
Erector Spinae Plane Block for Post-nephrectomy Pain
Official Title
Ultrasound Guided Continuous Erector Spinae Plane Block Versus Patient Controlled Analgesia in Patients Undergoing Nephrectomy for Renal Malignancies: A Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
March 3, 2020 (Actual)
Primary Completion Date
May 28, 2022 (Actual)
Study Completion Date
June 15, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Cancer Institute, Egypt

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Acute postoperative pain proper management is important not only for patient satisfaction but also for patient outcome. It may also predispose patients to chronic post-surgical pain .Open nephrectomy is still conducted, although the use of laparoscopic or robotic surgery has increased recently. A flank approach with an eleventh rib partial resection.Several modalities have been implemented for acute postoperative pain control. Intravenous (IV) opioids is one of the earliest and most widely used method, it is insufficient only for managing postoperative pain in some patients with severe pain besides their side effects.ESPB is a relatively simple technique with easily identified sonographic landmarks. Additionally, the ESPB has the potential to provide both somatic and visceral sensory blockade.The aim of this study is to evaluate the effect of ESPB in acute postoperative pain and opioid consumption in patients undergoing open nephrectomy in renal cancer patients.
Detailed Description
Acute postoperative pain proper management is important not only for patient satisfaction but also for patient outcome. In addition to its early effects, poorly controlled acute postoperative pain may predispose patients to chronic post-surgical pain. Open nephrectomy is still conducted, although the use of laparoscopic or robotic surgery has increased recently. A flank approach with an eleventh rib partial resection, which is the main method for open nephrectomy at our institution, could make for better dissection of the renal pelvis and the pedicles, and provide the best circumstances for nephrectomy; however, it induces more persistent pain compared with other approaches. Several modalities have been implemented for acute postoperative pain control. Intravenous (IV) opioids is one of the earliest and most widely used method, it is insufficient only for managing postoperative pain in some patients with severe pain. In addition, opioids have many side effects like respiratory depression, nausea, vomiting and constipation hence it is important to decrease opioids use and the transition to other modalities such as regional blocks, nerve blocks, NSAIDs and multimodalities.ESPB is a relatively simple technique with easily identified sonographic landmarks. Additionally, the ESPB has the potential to provide both somatic and visceral sensory blockade. The erector spinae muscle (ESM) is a complex formed by the spinalis, longissimus thoracis, and iliocostalis muscles that run vertically in the back. The ESP block is performed by depositing the local anesthetic (LA) in the fascial plane, deeper than the ESM at the tip of the transverse process of the vertebra. Hence, LA is distributed in the cranio-caudal fascial plane.Additionally, it diffuses anteriorly to the paravertebral and epidural spaces, and laterally to the intercostal space at several levels. There are different case studies about the use of erector spinae block in nephrectomy but there is no randomized controlled study about it until now so it will be one of the earliest studies that investigate the effect of ESPB to relief acute postoperative pain in patients undergoing open nephrectomy. The aim of this study is to evaluate the effect of ESPB in acute postoperative pain and opioid consumption in patients undergoing open nephrectomy in renal cancer patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
patient controlled analgesia
Arm Type
Active Comparator
Arm Description
30 patients will receive only postoperative IV PCA alone for postoperative analgesia.
Arm Title
Erector Spinae plane block
Arm Type
Active Comparator
Arm Description
30 patients will receive continuous ESPB for postoperative analgesia.
Intervention Type
Procedure
Intervention Name(s)
Morphine patient controlled analgesia
Intervention Description
30 patients will receive PCA only for postoperative analgesia
Intervention Type
Procedure
Intervention Name(s)
Erector Spinae plane block
Intervention Description
30 patients will receive continuous ESPB for postoperative analgesia
Primary Outcome Measure Information:
Title
measurement of visual analogue score
Description
it is a scoring system from 0 to 100 mm where 100 represents the worst pain and 0 indicates no pain
Time Frame
1 week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Physical status ASA II. Age ≥ 18 and ≤ 65 Years. Body mass index (BMI): > 20 kg/m2 and < 40 kg/m2. Exclusion Criteria: Patient refusal Known sensitivity or contraindication to local anesthetics. History of psychological disorders. Localized infection at the site of block. Coagulopathies with platelet count below 50,000 or an INR>1.5.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ehab H Gendy, MD
Organizational Affiliation
Assistant Professor of Anesthesia, intensive care and pain releif
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Cancer Institute
City
Cairo
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
we can share IPD after journal accepting the manuscript

Learn more about this trial

Erector Spinae Plane Block for Post-nephrectomy Pain

We'll reach out to this number within 24 hrs